Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novogen's lead anticancer compound continues to advance in clinical trials

Sep. 1, 2000

Cancer gene therapy with fusion molecule induces potent, selective apoptosis

Sep. 1, 2000

Aminobisphosphonates activate T-cells against multiple myeloma

Sep. 1, 2000

Matrix metalloproteinase inhibitors claimed by Aventis

Aug. 30, 2000

Testing reveals lurtotecan is less active than its low-clearance formulation

Aug. 30, 2000

Vion begins additional phase I trial of intravenous TAPET

Aug. 29, 2000

Research points to existence of a third hereditary breast cancer gene

Aug. 29, 2000

Inex broadens Onco TCS clinical trial program

Aug. 28, 2000

New testosterone derivatives patented by Schering AG

Aug. 28, 2000

Phase I trial of novel anticancer treatment under way

Aug. 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....